This inventor holds 1 USPTO granted patent. Top assignee: Bristol-Myers Squibb Compnay. Active years: 2009.
Company Filing History:
Years Active: 2009
Title: James J Devenny: Innovator in Obesity Treatment
Introduction
James J Devenny is a notable inventor based in Wayne, PA (US). He has made significant contributions to the field of obesity treatment through his innovative research and development of pharmaceutical compounds.
Latest Patents
Devenny holds a patent for the "Use of thianecarboxamides as DGAT inhibitors." This patent describes methods of treating obesity using DGAT-1 inhibitors according to a specific formula. The invention includes all prodrugs, solvates, pharmaceutically acceptable salts, and stereoisomers, wherein the components are detailed within the patent documentation.
Career Highlights
James J Devenny is associated with Bristol-Myers Squibb Company, a leading global biopharmaceutical company. His work focuses on developing effective treatments for obesity, showcasing his commitment to addressing significant health challenges.
Collaborations
Throughout his career, Devenny has collaborated with esteemed colleagues, including Dong Cheng and Jeffrey T Billheimer. These partnerships have contributed to the advancement of research in the pharmaceutical industry.
Conclusion
James J Devenny's innovative work in the field of obesity treatment highlights his role as a key inventor in the pharmaceutical sector. His contributions continue to impact the development of effective therapies for obesity.